Loibl, S., Loirat, D., Tolaney, S. M., Punie, K., Oliveira, M., Rugo, H. S., Bardia, A., Hurvitz, S. A., Brufsky, A. M., Kalinsky, K., Cortés, J., O’Shaughnessy, J. A., Dieras, V., Carey, L. A., Gianni, L., Gharaibeh, M., Preger, L., Phan, S., Chang, L., … Piccart, M. J. (2023). Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer. European Journal of Cancer, 178, 23–33. https://doi.org/10.1016/j.ejca.2022.10.003
Columbia Affiliation:
Subjects:
Immunoconjugates
(MeSH)
Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment
(OpenAlex Topic)
HER2 Signaling in Breast Cancer Treatment
(OpenAlex Topic)
Advancements in Colorectal Cancer Research
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1016/j.ejca.2022.10.003
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex